Research Article
Diagnostic Utility of Transbronchial Needle Aspiration in Malignant Endobronchial Lesions: Relevance to Lesions’ Characteristics
Table 3
Diagnostic yield of TBNA, CDT, and CDT plus TBNA with respect to the histopathologic subtype*.
| | Histopathologic subtype/lesion | TBNA no. (%) | CDT no. (%) | CDT + TBNA no. (%) | value |
| | NSCLC () | | | | | | EML () | 24 (82.8) | 25 (86.2) | 28 (96.6) | 0.25 | | SD () | 15 (100) | 13 (86.7) | 15 (100) | 0.5 | | PD () | 31 (91.2) | 20 (58.8) | 31 (91.2) | 0.001 |
| | Total () | 70 (90) | 58 (74.4) | 74 (95) | <0.001 |
| | SCLC () | | | | | | EML () | 3 (60) | 3 (60) | 5 (100) | 0.25 | | SD () | 6 (75) | 4 (50) | 7 (87.5) | 0.125 | | PD () | 3 (100) | 1 (33.3) | 3 (100) | 0.125 |
| | Total () | 12 (75) | 8 (50) | 15 (94) | 0.016 |
|
|
CDT versus TBNA + CDT; NSCLC: nonsmall cell lung cancer; SCLC: small cell lung cancer.
|
